The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders
Open accessAbstract
IMPORTANCE: Developmental brain disorders are a group of clinically and genetically heterogeneous disorders characterized by high heritability. Specific highly penetrant genetic causes can often be shared by a subset of individuals with different phenotypic features, and recent advances in genome sequencing have allowed the rapid and cost-effective identification of many of these pathogenic variants. OBJECTIVES: To identify novel candidate genes for developmental brain disorders and provide additional evidence of previously implicated genes. DATA SOURCES: The PubMed database was searched for studies published from March 28, 2003, through May 7, 2015, with large cohorts of individuals with developmental brain disorders. DATA EXTRACTION AND SYNTHESIS: A tiered, multilevel data-integration approach was used, which intersects (1) whole-genome data from structural and sequence pathogenic loss-of-function (pLOF) variants, (2) phenotype data from 6 apparently distinct disorders (intellectual disability, autism, attention-deficit/hyperactivity disorder, schizophrenia, bipolar disorder, and epilepsy), and (3) additional data from large-scale studies, smaller cohorts, and case reports focusing on specific candidate genes. All candidate genes were ranked into 4 tiers based on the strength of evidence as follows: tier 1, genes with 3 or more de novo pathogenic loss-of-function variants; tier 2, genes with 2 de novo pathogenic loss-of-function variants; tier 3, genes with 1 de novo pathogenic loss-of-function variant; and tier 4, genes with only inherited (or unknown inheritance) pathogenic loss-of-function variants. MAIN OUTCOMES AND MEASURES: Development of a comprehensive knowledge base of candidate genes related to developmental brain disorders. Genes were prioritized based on the inheritance pattern and total number of pathogenic loss-of-function variants identified amongst unrelated individuals with any one of six developmental brain disorders. STUDY SELECTION: A combination of phenotype-based and genotype-based literature review yielded 384 studies that used whole-genome or exome sequencing, chromosomal microarray analysis, and/or targeted sequencing to evaluate 1960 individuals with developmental brain disorders. RESULTS: Our initial phenotype-based literature review yielded 1911 individuals with pLOF variants involving 1034 genes from 118 studies. Filtering our results to genes with 2 or more pLOF variants identified in at least 2 unrelated individuals resulted in 241 genes from 1110 individuals. Of the 241 genes involved in brain disorders, 7 were novel high-confidence genes and 10 were novel putative candidate genes. Fifty-nine genes were ranked in tier 1, 44 in tier 2, 68 in tier 3, and 70 in tier 4. By transcending clinical diagnostic boundaries, the evidence level for 18 additional genes that were ranked 1 tier higher because of this cross-disorder approach was increased. CONCLUSIONS AND RELEVANCE: This approach increased the yield of gene discovery over what would be obtained if each disorder, type of genomic variant, and study design were analyzed independently. These results provide further support for shared genomic causes among apparently different disorders and demonstrate the clinical and genetic heterogeneity of developmental brain disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among 59 genes for each of which there are at least 10 total probands with de novo pLOF variants in the database, none are associated exclusively with ASD (Figure 1).”
From Insufficient Evidence for “Autism-Specific” Genes (2020) · cites this paper as [22]
In the citing paper
“For three genes, CHD8 [MIM: 610528], SHANK3 [MIM: 606230], and SCN2A [MIM: 182390], there are more individuals with ASD only than with ID only, but many have both ASD and ID, and for each of these genes, there are more individuals with ID than without ID (ID rates 68%, 52%, and 62% for CHD8, SHANK3, and SCN2A, respectively).”
From Insufficient Evidence for “Autism-Specific” Genes (2020) · cites this paper as [22]
In the citing paper
“At the time it was accessed, the database included 5,031 cases with loss-of-function variants in 553 genes based on information from 923 unique articles published between March 2003 and March 2019 that met curation criteria.22”
From Insufficient Evidence for “Autism-Specific” Genes (2020) · cites this paper as [22]
In the citing paper
“For example, the Geisinger Developmental Brain Disorder Genes Database (DBD Genes Database) integrates data from exome and genome sequencing, copy number array, and targeted gene studies with phenotype data for six clinically defined brain disorders (including ASD and ID) to examine the phenotypes associated with de novo pathogenic loss-of-function (pLoF) variants (see Web Resources).22”
From Insufficient Evidence for “Autism-Specific” Genes (2020) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Synaptic, transcriptional and chromatin genes disrupted in autism
Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746
The contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.14601 · Cited by 1,360
Large-scale discovery of novel genetic causes of developmental disorders
Study, T. D. D. D. (2015) · Nature · doi:10.1038/nature14135 · Cited by 1,124
Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders
Lee, H., Deignan, J. L., Dorrani, N., Strom, S. P., Kantarci, S., Quintero‐Rivera, F., Das, K., Toy, T. L., Harry, B., Yourshaw, M., et al. (2014) · JAMA · doi:10.1001/jama.2014.14604 · Cited by 991
Willsey, A. J., Sanders, S. J., Li, M., Dong, S., Tebbenkamp, A. T., Muhle, R. A., Reilly, S. K., Lin, L., Fertuzinhos, S., Miller, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.020 · Cited by 934
Cited by
Sorted by citations
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Genetic Testing in Neurodevelopmental Disorders
Savatt, J. M., & Myers, S. M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.526779 · Cited by 237
Pizzo, L., Jensen, M., Polyak, A., Rosenfeld, J. A., Mannik, K., Krishnan, A., McCready, E., Pichon, O., Le Caignec, C., Van Dijck, A., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0266-3 · Cited by 193
denovo-db: a compendium of humande novovariants
Turner, T. N., Qian, Y., Krumm, N., Huddleston, J., Hoekzema, K., Stessman, H. A. F., Doebley, A.-L., Bernier, R., Nickerson, D. A., & Eichler, E. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw865 · Cited by 221
A large data resource of genomic copy number variation across neurodevelopmental disorders
Zarrei, M., Burton, C. L., Engchuan, W., Young, E. J., Higginbotham, E. J., MacDonald, J. R., Trost, B., Chan, A. J. S., Walker, S., Lamoureux, S., et al. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0098-3 · Cited by 187
Lee, C., Bendriem, R. M., Wu, W. W., & Shen, R. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0362-8 · Cited by 208
Insufficient Evidence for “Autism-Specific” Genes
Myers, S. M., Challman, T. D., Bernier, R., Bourgeron, T., Chung, W. K., Constantino, J. N., Eichler, E. E., Jacquemont, S., Miller, D. T., Mitchell, K. J., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.04.004 · Cited by 165
Self-citationA framework for an evidence-based gene list relevant to autism spectrum disorder
Schaaf, C. P., Betancur, C., Yuen, R. K. C., Parr, J. R., Skuse, D., Gallagher, L., Bernier, R., Buchanan, J. A., Buxbaum, J. D., Chen, C., et al. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0231-2 · Cited by 144
Assessing the evidence for shared genetic risks across psychiatric disorders and traits
Martin, J., Taylor, M. J., & Lichtenstein, P. (2017) · Psychological Medicine · doi:10.1017/s0033291717003440 · Cited by 141
Leblond, C. S., Le, T.-L., Malesys, S., Cliquet, F., Tabet, A., Delorme, R., Rolland, T., & Bourgeron, T. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103623 · Cited by 144
Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy
Moreno-De-Luca, A., Millan, F., Pesacreta, D. R., Elloumi, H. Z., Oetjens, M. T., Teigen, C., Wain, K. E., Scuffins, J., Myers, S. M., Torene, R. I., et al. (2021) · JAMA · doi:10.1001/jama.2020.26148 · Cited by 129
Self-citationHomberg, J. R., Kyzar, E. J., Nguyen, M., Norton, W., Pittman, J. T., Poudel, M. K., Gaikwad, S., Nakamura, S., Koshiba, M., Yamanouchi, H., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.013 · Cited by 86
A framework to identify contributing genes in patients with Phelan-McDermid syndrome
Tabet, A., Rolland, T., Ducloy, M., Lévy, J., Buratti, J., Mathieu, A., Haye, D., Perrin, L., Dupont, C., Passemard, S., et al. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0035-2 · Cited by 87
Gene4Denovo: an integrated database and analytic platform for de novo mutations in humans
Zhao, G., Li, K., Li, B., Wang, Z., Fang, Z., Wang, X., Zhang, Y., Luo, T., Zhou, Q., Wang, L., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz923 · Cited by 64
Phenotypic spectrum of NRXN1 mono‐ and bi‐allelic deficiency: A systematic review
Castronovo, P., Baccarin, M., Ricciardello, A., Picinelli, C., Tomaiuolo, P., Cucinotta, F., Frittoli, M., Lintas, C., Sacco, R., & Persico, A. M. (2020) · Clinical Genetics · doi:10.1111/cge.13537 · Cited by 65
Novel mutations in NLGN3 causing autism spectrum disorder and cognitive impairment
Quartier, A., Courraud, J., Ha, T., McGillivray, G., Isidor, B., Rose, K., Drouot, N., Savidan, M., Feger, C., Jagline, H., et al. (2019) · Human Mutation · doi:10.1002/humu.23836 · Cited by 67
Understanding mutational effects in digenic diseases
Gazzo, A. M., Raimondi, D., Daneels, D., Moreau, Y., Smits, G., Dooren, S. V., & Lenaerts, T. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx557 · Cited by 59
Kushima, I., Nakatochi, M., Aleksić, B., Okada, T., Kimura, H., Kato, H., Morikawa, M., Inada, T., Ishizuka, K., Torii, Y., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.003 · Cited by 60
Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variants
Chan, A. J. S., Cytrynbaum, C. S., Hoang, N., Ambrozewicz, P., Weksberg, R., Drmic, I., Ritzema, A. M., Schachar, R. J., Walker, S., Uddin, M. J., et al. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0083-x · Cited by 51
Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders
Chow, J. C., Jensen, M., Amini, H., Hormozdiari, F., Penn, O., Shifman, S., Girirajan, S., & Hormozdiari, F. (2019) · Genome Medicine · doi:10.1186/s13073-019-0678-y · Cited by 45
Early-life stress links 5-hydroxymethylcytosine to anxiety-related behaviors
Papale, L. A., Madrid, A., Li, S., & Alisch, R. S. (2017) · Epigenetics · doi:10.1080/15592294.2017.1285986 · Cited by 42
An interaction-based model for neuropsychiatric features of copy-number variants
Jensen, M., & Girirajan, S. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007879 · Cited by 39
Liaci, C., Camera, M., Caslini, G., Rando, S., Contino, S., Romano, V., & Merlo, G. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116167 · Cited by 40
Mapping a shared genetic basis for neurodevelopmental disorders
Jensen, M., & Girirajan, S. (2017) · Genome Medicine · doi:10.1186/s13073-017-0503-4 · Cited by 40
Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder
Courraud, J., Chater‐Diehl, E., Durand, B., Vincent, M., Moreno, M. D. M. M., Boujelbene, I., Drouot, N., Genschik, L., Schaefer, É., Nizon, M., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01263-1 · Cited by 37
Viswanath, B., Rao, N. P., Narayanaswamy, J. C., Sivakumar, P. T., Kandasamy, A., Kesavan, M., Mehta, U. M., Venkatasubramanian, G., John, J. P., Mukherjee, O., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1674-2 · Cited by 33
Kuan, P. F., Clouston, S., Yang, X., Kotov, R., Bromet, E. J., & Luft, B. J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00958-4 · Cited by 34
Lewis, E. M. A., Meganathan, K., Baldridge, D., Gontarz, P. M., Zhang, B., Bonni, A., Constantino, J. N., & Kroll, K. L. (2019) · Molecular Autism · doi:10.1186/s13229-019-0306-0 · Cited by 32
Whole-exome sequencing identifies a novel de novo mutation in DYNC1H1 in epileptic encephalopathies
Lin, Z., Liu, Z., Li, X., Feng, L., Hu, Y., Chen, B., Wang, Z., & Liu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00208-6 · Cited by 32
Romanovsky, E., Choudhary, A., Peles, D., Abu-Akel, A. M., & Stern, S. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02740-0 · Cited by 27
Lencz, T., Yu, J., Khan, R. R., Flaherty, E. K., Carmi, S., Lam, M., Ben‐Avraham, D., Barzilai, N., Bressman, S., Darvasi, A., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.004 · Cited by 30
Griesius, S., O’Donnell, C., Waldron, S., Thomas, K. L., Dwyer, D. M., Wilkinson, L. S., Hall, J., Robinson, E. S. J., & Mellor, J. R. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01277-6 · Cited by 31
Genes essential for embryonic stem cells are associated with neurodevelopmental disorders
Shohat, S., & Shifman, S. (2019) · Genome Research · doi:10.1101/gr.250019.119 · Cited by 21
Genome-wide rare variant score associates with morphological subtypes of autism spectrum disorder
Chan, A. J. S., Engchuan, W., Reuter, M. S., Wang, Z., Thiruvahindrapuram, B., Trost, B., Nalpathamkalam, T., Negrijn, C., Lamoureux, S., Pellecchia, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34112-z · Cited by 31
More, R. P., Warrier, V., Brunel, H., Buckingham, C., Smith, P. L., Allison, C. L., Holt, R., Bradshaw, C. R., & Baron‐Cohen, S. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01938-4 · Cited by 25
Computational resources associating diseases with genotypes, phenotypes and exposures
Zhang, W., Zhang, H., Yang, H., Li, M., Xie, Z., & Li, W. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby071 · Cited by 26
Kim, H. H., An, J., & Park, Y. R. (2021) · JMIR Serious Games · doi:10.2196/23130 · Cited by 26
Shimelis, H., Oetjens, M. T., Walsh, L. K., Wain, K. E., Znidarsic, M., Myers, S. M., Finucane, B. M., Ledbetter, D. H., & Martin, C. L. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22010062 · Cited by 25
Self-citationSex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress
Papale, L. A., Li, S., Madrid, A., Zhang, Q., Chen, L., Chopra, P., Jin, P., Keleş, S., & Alisch, R. S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.014 · Cited by 26
Alisch, R. S., Van Hulle, C., Chopra, P., Bhattacharyya, A., Zhang, S.-C., Davidson, R. J., Kalin, N. H., & Goldsmith, H. H. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0047-9 · Cited by 25
SATB2 organizes the 3D genome architecture of cognition in cortical neurons
Wahl, N., Espeso‐Gil, S., Chietera, P., Nagel, A., Laighneach, A., Morris, D. W., Rajarajan, P., Akbarian, S., Dechant, G., & Apostolova, G. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.024 · Cited by 24
Cross-Disorder Psychiatric Genomics
Docherty, A. R., Moscati, A., & Fanous, A. H. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0084-3 · Cited by 26
Methionine sulfoxide reductase (Msr) dysfunction in human brain disease
Reiterer, M., Schmidt‐Kastner, R., & Milton, S. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1662899 · Cited by 26
Whitford, V., Byers, N., O’Driscoll, G. A., & Titone, D. A. (2023) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2023.100289 · Cited by 24
Riggs, E. R., Bingaman, T. I., Barry, C.-A., Behlmann, A., Bluske, K. K., Bostwick, B. L., Bright, A., Chen, C., Clause, A. R., Dharmadhikari, A. V., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.05.001 · Cited by 26
Self-citationThe Phenotypic Spectrum of 15q13.3 Region Duplications: Report of 5 Patients
Budișteanu, M., Papuc, S. M., Streață, I., Cucu, M., Pîrvu, A., Sosoi, S. S., Erbescu, A., Andrei, L. E., Iliescu, C., Ioana, D., et al. (2021) · Genes · doi:10.3390/genes12071025 · Cited by 25
Egawa, J., Hoya, S., Watanabe, Y., Nunokawa, A., Shibuya, M., Ikeda, M., Inoue, E., Okuda, S., Kondo, K., Saito, T., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32444 · Cited by 21
Jin, J., Liu, L., Chen, W., Gao, Q., Li, H., Wang, Y., & Qian, Q. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00882 · Cited by 21
Brooks, J. D., Arneja, J., Fu, L., Saxena, F. E., Tu, K., Pinzaru, B., Anagnostou, E. A., Nylen, K., Saunders, N. R., Lu, H., et al. (2021) · Autism Research · doi:10.1002/aur.2491 · Cited by 22
Kimura, H., Wang, C., Ishizuka, K., Xing, J., Takasaki, Y., Kushima, I., Aleksić, B., Uno, Y., Okada, T., Ikeda, M., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.023 · Cited by 21
Shohat, S., Amelan, A., & Shifman, S. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.019 · Cited by 19
Carias, K. V., & Wevrick, R. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.023 · Cited by 19
Papale, L. A., Madrid, A., Zhang, Q., Chen, K., Sak, L., Keleş, S., & Alisch, R. S. (2021) · Genome Research · doi:10.1101/gr.276137.121 · Cited by 18
Genetic modifiers and ascertainment drive variable expressivity of complex disorders
Jensen, M., Smolen, C., Tyryshkina, A., Pizzo, L., Sun, J., Noss, S., Banerjee, D., Oetjens, M. T., Shimelis, H., Taylor, C. M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.09.012 · Cited by 21
Self-citationProximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5
Yheskel, M., Sidoli, S., & Secombe, J. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00481-y · Cited by 18
PsyMuKB: An Integrative De Novo Variant Knowledge Base for Developmental Disorders
Lin, G. N., Guo, S., Xian, T., Wang, W., Qian, W., Song, W., Wang, J., Yu, S., Wang, Z., Cui, D., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.10.002 · Cited by 16
The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis
Yu, J., Liao, X., Zhong, Y., Wu, Y., Lai, X., Jiao, H., Yan, M., Zhang, Y., Ma, C., & Wang, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770145 · Cited by 17
Genetic Counseling for Autism Spectrum Disorder in an Evolving Theoretical Landscape
Finucane, B. M., & Myers, S. M. (2016) · Current Genetic Medicine Reports · doi:10.1007/s40142-016-0099-9 · Cited by 16
Sensory Gating in Neurodevelopmental Disorders: A Scoping Review
Schulz, S. E., Luszawski, M., Hannah, K. E., & Stevenson, R. A. (2023) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-023-01058-9 · Cited by 18
Gene discoveries in autism are biased towards comorbidity with intellectual disability
Jensen, M., Smolen, C., & Girirajan, S. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106476 · Cited by 15
Characterization of speech and language phenotype in children with NRXN1 deletions
Brignell, A., John, M. S., Boys, A., Bruce, A., Dinale, C., Pigdon, L., Hildebrand, M. S., Amor, D. J., & Morgan, A. T. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32664 · Cited by 15
Suárez, A. S., Menéndez, B. M., Escamilla, E. E., Sarriés, F. J. M., Garrido, M. I. E., Gil-Fournier, B., León, S. R., Gribble, B. R., Quesada‐Espinosa, J. F., & Romero, A. J. A. (2024) · Genes · doi:10.3390/genes15101310 · Cited by 16
Efthymiou, S., Leo, C. P., Deng, C., Lin, S., Maroofian, R., Lin, R., Karagoz, I., Zhang, K., Kaiyrzhanov, R. B., Scardamaglia, A., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.03.015 · Cited by 11
Myers, S. M., & Challman, T. D. (2018) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610021357-19 · Cited by 12
DeepND: Deep multitask learning of gene risk for comorbid neurodevelopmental disorders
Beyreli, İ., Karakahya, O., & Çiçek, A. E. (2022) · Patterns · doi:10.1016/j.patter.2022.100524 · Cited by 13
Yang, A., Chen, J., & Zhao, X. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa298 · Cited by 10
Chen, H., Ferguson, C., Mitchell, D. C., Risch, I., Titus, A., Paulo, J. A., Hwang, A., Beck, L. P., Lin, T., Gu, W. J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115231 · Cited by 12
Jensen, M., Tyryshkina, A., Pizzo, L., Smolen, C., Das, M., Huber, E., Krishnan, A., & Girirajan, S. (2021) · Genome Medicine · doi:10.1186/s13073-021-00982-z · Cited by 10
Chen, C., Chen, D., Xue, H., Liu, X., Zhang, T., Tang, S., Li, W., & Xu, X. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.027 · Cited by 11
Identification of De Novo DNMT3A Mutations That Cause West Syndrome by Using Whole-Exome Sequencing
Liu, Z., Li, Z., Zhi, X., Du, Y., Lin, Z., & Wu, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0483-9 · Cited by 12
Zhang, Y., Wang, T., Wang, Y., Xia, K., Li, J., & Sun, Z. S. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02377-y · Cited by 10
DYRK1A roles in human neural progenitors
Courraud, J., Quartier, A., Drouot, N., Zapata-Bodalo, I., Gilet, J., Benchoua, A., Mandel, J., & Piton, A. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1533253 · Cited by 9
KPTN gene homozygous variant‐related syndrome in the northeast of Brazil: A case report
de Lucena, P. H. M., Armani‐Franceschi, G., Bispo‐Torres, A. C., Bandeira, I. D., Lucena, M. F. G., Maldonado, I. L., Veiga, M., Miguel, D., & Lucena, R. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61492 · Cited by 9
Ishizuka, K., Kimura, H., Yoshimi, A., Banno, M., Kushima, I., Uno, Y., Okada, T., Mori, D., Aleksić, B., & Ozaki, N. (2016) · PubMed Central · doi:10.18999/nagjms.78.4.465 · Cited by 9
Capkova, Z., Čapková, P., Srovnal, J., Štaffová, K., Becvarova, V., Trková, M., Adamová, K., Santavá, A., Curtisová, V., Hajdúch, M., et al. (2019) · PeerJ · doi:10.7717/peerj.7979 · Cited by 11
Wu, Y., Zhong, Y., Liao, X., Miao, X., Yu, J., Lai, X., Zhang, Y., Ma, C., Pan, H., & Wang, S. (2022) · Molecular Brain · doi:10.1186/s13041-022-00918-7 · Cited by 7
Karunakaran, K. B., Gabriel, G. C., Balakrishnan, N., Lo, C. W. Y., & Ganapathiraju, M. K. (2022) · Genes · doi:10.3390/genes13040627 · Cited by 5
Intellectual disability, the long way from genes to biological mechanisms
Martí, M., Millan, M. I. P., Young, J. I., & Walz, K. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.10 · Cited by 7
Genetic modifiers and ascertainment drive variable expressivity of complex disordersPreprint
Jensen, M., Smolen, C., Tyryshkina, A., Pizzo, L., Banerjee, D., Oetjens, M. T., Shimelis, H., Taylor, C. M., Pounraja, V. K., Song, H., et al. (2024) · medRxiv · doi:10.1101/2024.08.27.24312158 · Cited by 5
Self-citationExtra-cerebral recombination activity of Emx1-Cre and nestin-Cre in the kidney
Wang, M., Liu, X., Fang, Y., & Li, Q. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1480217 · Cited by 5
Zion, T. N., Wayburn, B., Darabi, S., Thrush, D. L., Smith, E. D., Johnston, T., Martin, B., Hagman, K. D. F., Parra, M. C., & Antolik, C. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.630 · Cited by 6
Big Data: Knowledge Discovery and Data Repositories
Velupillai, S. U., Davis, K. A. S., & Rozenblit, L. (2021) · Health informatics · doi:10.1007/978-3-030-70558-9_15 · Cited by 4
Suresh, A., Kourdougli, N., Nomura, T., Buth, J. E., Miranda‐Rottmann, S., Sánchez-León, C. A., Wu, M. W., Nelson, S. M., Wall, L. T., Tran, A., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.032 · Cited by 3
Gim, D. H., Assir, M. Z. K., Soper, O., Fowler, P., Morgan, M. D., Berg, D. A., & Kang, E. (2025) · Nature Communications · doi:10.1038/s41467-025-64381-3 · Cited by 4
Bizzotto, M., You, S. F., Tamborini, M., Faggiani, E., Morini, R., Borreca, A., Zhang, R., Aladyeva, E., Nallapu, A., Ferrari, C., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.043 · Cited by 4
Delving into the Genetic Causes of Language Impairment in a Case of Partial Deletion of NRXN1
Benítez‐Burraco, A., Jiménez-Romero, M. S., & Fernández-Urquiza, M. (2022) · Molecular Syndromology · doi:10.1159/000524710 · Cited by 4
Benoit, C. R., Sattler, L. B., Aylward, A. J., Pembridge, O. G., Kim, B., Muratore, C., Liao, M., He, A., Ashour, N., Fancher, S. B., et al. (2025) · Brain · doi:10.1093/brain/awaf221 · Cited by 3
Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders
Li, K., Fang, Z., Zhao, G., Li, B., Chen, C., Xia, L., Wang, L., Luo, T., Wang, X., Wang, Z., et al. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05031-7 · Cited by 4
Tabet, A., Rolland, T., Ducloy, M., Lévy, J., Buratti, J., Mathieu, A., Haye, D., Perrin, L., Dupont, C., Passemard, S., et al. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0090-y · Cited by 3
Deep multitask learning of gene risk for comorbid neurodevelopmental disordersPreprint
Beyreli, İ., Karakahya, O., & Çiçek, A. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.13.150201 · Cited by 3
Kealhofer, M., Brown, R. C., Riley, B. P., & Nguyen, T.-H. (2025) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaf162 · Cited by 2
Circadian rhythms in microglia mediate early life synaptic development in a sex-specific manner
Routh, B. N., Gibson, C. R., Yang, C. C., Doan, L., Gaudet, A. D., Hofmann, H. A., Mangieri, R. A., & Fonken, L. K. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117834 · Cited by 2
Mehta, D., & Czamara, D. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_105 · Cited by 2
Targeted sequencing identifies risk variants in 202 candidate genes for neurodevelopmental disorders
Pang, N., Li, K., Tan, S., Chen, M., He, F. P., Chen, C., Yang, L., Zhang, C., Deng, X., Yang, L. C., et al. (2023) · Gene · doi:10.1016/j.gene.2023.148071 · Cited by 2
Cross-Disorder Analysis of De Novo Variants Increases the Power of Prioritising Candidate Genes
Li, K., Ling, Z., Luo, T., Zhao, G., Zhou, Q., Wang, X., Xia, K., Li, J., & Li, B. (2021) · Life · doi:10.3390/life11030233 · Cited by 2
Analysis of genetic overlap between inborn errors of immunity and neurodevelopmental disordersPreprint
Serra, I., Koning, M. D., van der Spek, P. J., Dalm, V. A. S. H., & Badura, A. (2025) · medRxiv · doi:10.1101/2025.03.01.25323148 · Cited by 2
Patterns of typical and atypical neurodevelopment
Lazar, S. M., Svoboda, M., Risen, S., & Myers, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824060-1.00026-2 · Cited by 1
Influence of cross-disorder analyses on the diagnostic criteria of mental illnesses.
Wang, M., & Cui, D. (2016) · Europe PMC (PubMed Central) · doi:10.11919/j.issn.1002-0829.216032 · Cited by 2
Rehabilitation for Developmental Disabilities
Ogura, K. (2016) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.53.365 · Cited by 1
Davis, K., Serrano, M. A., Martin, M. M., Vanzo, R. J., Rimmasch, M., Hom, Y., Uddin, M. J., & Bilancia, C. G. (2021) · Scientific Reports · doi:10.1016/s1096-7192(21)00488-1 · Cited by 1
Metadata
- Authors
- Gonzalez-Mantilla, A. J., Moreno-De-Luca, A., Ledbetter, D. H., & Martin, C. L.
- Affiliations
- Autism & Developmental Medicine Institute (US)
- Autism & Developmental Medicine Institute, Geisinger Health System, Danville, Pennsylvania2Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania3Department of Radiology, Geisinger Health System, Danville, Pennsylvania
- Corresponding author
- Martin, Christa Lese
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2016-03-01
- Volume
- 73
- Issue
- 3
- Pages
- 275
- ISSN
- 2168-622X (ISSN-L)
- PMC
- PMC5333489
- OpenAlex
- W2258597767
- Cited by
- 139
- References
- 32
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 21 · 2020: 12 · 2019: 21 · 2018: 7 · 2017: 10 · 2016: 12
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH074090)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- neurodevelopmental disorders, candidate genes, de novo mutations, intellectual disability, autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, bipolar disorder, epilepsy, gene prioritization, cross-disorder analysis, genetic heterogeneity, mode of inheritance, novel genes, phenotypic overlap, structural variants
- MeSH terms
- Alleles, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Bipolar Disorder, Brain Diseases, Developmental Disabilities, Humans, Phenotype, Genome, Human, Genetic Predisposition to Disease, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
